X0708 D LIVE 0001638287 MetaVia Inc. 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA MASSACHUSETTS 02138 857-702-9600 DELAWARE NeuroBo Therapeutics, Inc. NeuroBo Pharmaceuticals, Inc. Gemphire Therapeutics Inc. Corporation true Hyung Heon Kim 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Director Marshall H. Woodworth 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Executive Officer Mark A. Glickman 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Jason L. Groves 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Andrew Koven 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Michael Salsbury 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director D. Gordon Strickland 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director James P. Tursi 545 Concord Avenue Suite 210 Cambridge MA MASSACHUSETTS 02138 Director Biotechnology Decline to Disclose 06b false 2025-05-08 false true true true false 0 Ladenburg Thalmann & Co. Inc. 000000505 None None 640 5th Avenue 4th Floor New York NY NEW YORK 10019 CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS KY KENTUCKY MD MARYLAND MA MASSACHUSETTS MN MINNESOTA NV NEVADA NJ NEW JERSEY NY NEW YORK OR OREGON PA PENNSYLVANIA TX TEXAS WA WASHINGTON true 10000000 10000000 0 This Form D is being filed solely with respect to the sale of 9,479,345 shares of common stock and 4,605,162 pre-funded warrants to purchase shares of common stock. Includes expected proceeds of up to $4,605.16 from the exercise of the prefunded warrants. false 2 422749 0 0 false MetaVia Inc. /s/ Hyung Heon Kim Hyung Heon Kim President, Chief Executive Officer and Director 2025-05-15